New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS Jeffrey S, Medscape, 12 Feb 2016 Accessed on 16 Feb 2016 from http://www.medscape.com/viewarticle/858883. CommentRecommendBookmarkWatch